Literature DB >> 21116958

Detecting and measuring free gadolinium in nanoparticles for MRI imaging.

Jeffrey D Clogston1, Anil K Patri.   

Abstract

This chapter describes a method for the measurement of free gadolinium in nanoparticle samples. Conjugation of a gadolinium-chelate to a nanoparticle allows the particle's distribution to be imaged via magnetic resonance imaging (MRI). Free (unchelated) gadolinium is a known toxin, being a heavy metal, and may contribute towards total gadolinium concentration. Determining the amount of free gadolinium is therefore an important aspect of the preclinical characterization of gadolinium-chelate MRI imaging agent nanoparticles.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21116958     DOI: 10.1007/978-1-60327-198-1_10

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  2 in total

1.  Formulation development of a novel targeted theranostic nanoemulsion of docetaxel to overcome multidrug resistance in ovarian cancer.

Authors:  Srinivas Ganta; Amit Singh; Yashesh Rawal; Joseph Cacaccio; Niravkumar R Patel; Praveen Kulkarni; Craig F Ferris; Mansoor M Amiji; Timothy P Coleman
Journal:  Drug Deliv       Date:  2014-06-05       Impact factor: 6.419

2.  Development of EGFR-targeted nanoemulsion for imaging and novel platinum therapy of ovarian cancer.

Authors:  Srinivas Ganta; Amit Singh; Niravkumar R Patel; Joseph Cacaccio; Yashesh H Rawal; Barbara J Davis; Mansoor M Amiji; Timothy P Coleman
Journal:  Pharm Res       Date:  2014-03-19       Impact factor: 4.200

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.